What does PHARMACIE BESONRIEUX CENTRE do?

PHARMACIE BESONRIEUX CENTRE is a pharmacy in La Louvière. Private Limited, started on 27 October 2023.

What is the address of PHARMACIE BESONRIEUX CENTRE?

The registered office of PHARMACIE BESONRIEUX CENTRE is located at Rue de Bois d'Haine(Be) 17 box 1, 7100 La Louvière.

Is PHARMACIE BESONRIEUX CENTRE still active?

Yes. According to the CBE (19 September 2026) PHARMACIE BESONRIEUX CENTRE is active, legal situation “Normale toestand”, started on 27 October 2023.

Is PHARMACIE BESONRIEUX CENTRE registered on Peppol?

Yes, PHARMACIE BESONRIEUX CENTRE is registered on the Peppol network with ID 0208:1001695640.

What is the enterprise number of PHARMACIE BESONRIEUX CENTRE?

The enterprise number of PHARMACIE BESONRIEUX CENTRE is BE1001695640.

When was PHARMACIE BESONRIEUX CENTRE founded?

PHARMACIE BESONRIEUX CENTRE was founded on 27 October 2023.

Who are the directors of PHARMACIE BESONRIEUX CENTRE?

According to the 2025 annual accounts, the directors of PHARMACIE BESONRIEUX CENTRE are: DEVANTHINIC PHARMA.

Is PHARMACIE BESONRIEUX CENTRE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 October 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE BESONRIEUX CENTRE make in 2025?

PHARMACIE BESONRIEUX CENTRE posted a profit after taxes of € 15,132 in financial year 2025.

What is the revenue of PHARMACIE BESONRIEUX CENTRE?

As a small company, PHARMACIE BESONRIEUX CENTRE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 81,334.

How much does an employee at PHARMACIE BESONRIEUX CENTRE earn?

The average wage cost per full-time employee at PHARMACIE BESONRIEUX CENTRE was € 49,400 in 2025: staff costs of € 59,310 for 1.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE BESONRIEUX CENTRE have?

According to the 2025 annual accounts, PHARMACIE BESONRIEUX CENTRE has 1.2 full-time equivalents (FTE).

PHARMACIE BESONRIEUX CENTRE (Private Limited)

Dossier PHARMACIE BESONRIEUX CENTRE, printed on 19 September 2026 from databakkes.be/en/1001695640/pharmacie-besonrieux-centre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE BESONRIEUX CENTRE from La Louvière, company number BE1001695640, closed financial year 2025 with a result of € 15,132 after tax. For that financial year PHARMACIE BESONRIEUX CENTRE recorded a gross margin of € 81,334 and equity of € 8,035. Compared with financial year 2024, the result moved from € -14,370 to € 15,132. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 8,035

▲ € 15,132 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 15,132

▲ still € 14,370 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 188,048

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 7,411.

People and assets in 2025

Full-time equivalents

1.2

▼ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 59,310

▼ 64% vs 2024

€ 49,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 104,492

▼ 24% vs 2024

€ 11,414 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 31,191

▼ 78% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 7,548

▲ 3% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 152,232 Gross margin 2024: € 152,232 First fiscal year in the series	€ 81,334 Gross margin 2025: € 81,334 ▼ 47% vs 2024 (€ 152,232) Unfavourable step	▼ 47%
Profit after taxes	€ -14,370 Profit after taxes 2024: € -14,370 First fiscal year in the series	€ 15,132 Profit after taxes 2025: € 15,132 ▲ € 29,502 vs 2024 (€ -14,370) Favourable step	▲ € 29,502
Equity	€ -7,097 Equity 2024: € -7,097 First fiscal year in the series	€ 8,035 Equity 2025: € 8,035 ▲ € 15,132 vs 2024 (€ -7,097) Favourable step	▲ € 15,132
Total debts	€ 333,743 Total debts 2024: € 333,743 First fiscal year in the series	€ 369,174 Total debts 2025: € 369,174 ▲ 11% vs 2024 (€ 333,743) Unfavourable step	▲ 11%
Cash	€ 164,606 Cash 2024: € 164,606 First fiscal year in the series	€ 188,048 Cash 2025: € 188,048 ▲ 14% vs 2024 (€ 164,606) Favourable step	▲ 14%
Retained profit	€ -7,721 Retained profit 2024: € -7,721 First fiscal year in the series	€ 7,411 Retained profit 2025: € 7,411 ▲ € 15,132 vs 2024 (€ -7,721) Favourable step	▲ € 15,132
Bank debt	€ 137,507 Bank debt 2024: € 137,507 First fiscal year in the series	€ 104,492 Bank debt 2025: € 104,492 ▼ 24% vs 2024 (€ 137,507) Favourable step	▼ 24%
Balance sheet total	€ 326,646 Balance sheet total 2024: € 326,646 First fiscal year in the series	€ 377,209 Balance sheet total 2025: € 377,209 ▲ 15% vs 2024 (€ 326,646) Unchanged	▲ 15%
Employees (FTE)	1.4 Employees (FTE) 2024: 1.4 First fiscal year in the series	1.2 Employees (FTE) 2025: 1.2 ▼ 0.2 vs 2024 (1.4) Unchanged	▼ 0.2

Key figures of PHARMACIE BESONRIEUX CENTRE, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE BESONRIEUX CENTRE?

What happened at PHARMACIE BESONRIEUX CENTRE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 15,132. filed late Source: NBB ↗
2023 DEVANTHINIC PHARMA became a director. NBB
Oct 27, 2023 Start of the company according to the CBE. KBO

In short

From € 14,370 loss in 2024 to € 15,132 profit in 2025.

Paid € 1,849 in corporate taxes since 2024.

Best year ever: 2025, with € 15,132 profit.

On average € 67,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE BESONRIEUX CENTRE? We notify you, reason included.

Follow PHARMACIE BESONRIEUX CENTRE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit